Data / Form D filings / Pacific Diabetes Technologies, Inc.
Pacific Diabetes Technologies, Inc.: Form D filings
Pacific Diabetes Technologies, Inc., a biotechnology company in Portland, OR, filed 6 Form D notices with the SEC between 2021 and 2025. The latest, on November 17, 2025, reports $3.4 million sold of a $3.5 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12172 SW GARDEN PL, Portland, OR, 97223
- Phone
- (503) 847-9170
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1835476
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Amendment | $3,500,000 | $3,385,000 | $115,000 | 15 | Oct 6, 2025 | sec.gov |
| Oct 20, 2025 | New notice | $3,000,000 | $2,920,000 | $80,000 | 4 | Oct 6, 2025 | sec.gov |
| Mar 14, 2025 | New notice | $5,000,000 | $2,057,533 | $2,942,467 | 5 | Mar 13, 2025 | sec.gov |
| Sep 9, 2024 | Amendment | $5,000,000 | $1,540,000 | $3,460,000 | 17 | Sep 5, 2023 | sec.gov |
| Sep 13, 2023 | New notice | $5,000,000 | $500,000 | $4,500,000 | 1 | Sep 5, 2023 | sec.gov |
| Jun 2, 2021 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas Seidl | Executive Officer, Director, Promoter | |
| Hank Wuh | Director | |
| Christopher Marsh | Director |
Other biotechnology companies in Oregon that filed recently
- UBIVAC, INC. $80,000 · Aug 27, 2026
- Trace Biosciences Inc. $8.3 million · Aug 12, 2026
Every Form D from the week of Nov 17, 2025 · All recent filings in Oregon · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pacific Diabetes Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.